Cargando…
A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
BACKGROUND: Currently, a surgical approach is the best curative treatment for those with hepatocellular carcinoma (HCC). However, this requires HCC detection and removal of the lesion at an early stage. Unfortunately, most cases of HCC are detected at an advanced stage because of the lack of accurat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980825/ https://www.ncbi.nlm.nih.gov/pubmed/24564861 http://dx.doi.org/10.1186/1755-8794-6-S3-S9 |
_version_ | 1782479589111496704 |
---|---|
author | Wang, Mengjun Mehta, Anand Block, Timothy M Marrero, Jorge Di Bisceglie, Adrian M Devarajan, Karthik |
author_facet | Wang, Mengjun Mehta, Anand Block, Timothy M Marrero, Jorge Di Bisceglie, Adrian M Devarajan, Karthik |
author_sort | Wang, Mengjun |
collection | PubMed |
description | BACKGROUND: Currently, a surgical approach is the best curative treatment for those with hepatocellular carcinoma (HCC). However, this requires HCC detection and removal of the lesion at an early stage. Unfortunately, most cases of HCC are detected at an advanced stage because of the lack of accurate biomarkers that can be used in the surveillance of those at risk. It is believed that biomarkers that could detect HCC early will play an important role in the successful treatment of HCC. METHODS: In this study, we analyzed serum levels of alpha fetoprotein, Golgi protein, fucosylated alpha-1-anti-trypsin, and fucosylated kininogen from 113 patients with cirrhosis and 164 serum samples from patients with cirrhosis plus HCC. We utilized two different methods, namely, stepwise penalized logistic regression (stepPLR) and model-based classification and regression trees (mob), along with the inclusion of clinical and demographic factors such as age and gender, to determine if these improved algorithms could be used to increase the detection of cancer. RESULTS AND DISCUSSION: The performance of multiple biomarkers was found to be better than that of individual biomarkers. Using several statistical methods, we were able to detect HCC in the background of cirrhosis with an area under the receiver operating characteristic curve of at least 0.95. stepPLR and mob demonstrated better predictive performance relative to logistic regression (LR), penalized LR and classification and regression trees (CART) used in our prior study based on three-fold cross-validation and leave one out cross-validation. In addition, mob provided unparalleled intuitive interpretation of results and potential cut-points for biomarker levels. The inclusion of age and gender improved the overall performance of both methods among all models considered, while the stratified male-only subset provided the best overall performance among all methods and models considered. CONCLUSIONS: In addition to multiple biomarkers, the incorporation of age and gender into statistical models significantly improved their predictive performance in the detection of HCC. |
format | Online Article Text |
id | pubmed-3980825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39808252014-04-24 A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables Wang, Mengjun Mehta, Anand Block, Timothy M Marrero, Jorge Di Bisceglie, Adrian M Devarajan, Karthik BMC Med Genomics Research BACKGROUND: Currently, a surgical approach is the best curative treatment for those with hepatocellular carcinoma (HCC). However, this requires HCC detection and removal of the lesion at an early stage. Unfortunately, most cases of HCC are detected at an advanced stage because of the lack of accurate biomarkers that can be used in the surveillance of those at risk. It is believed that biomarkers that could detect HCC early will play an important role in the successful treatment of HCC. METHODS: In this study, we analyzed serum levels of alpha fetoprotein, Golgi protein, fucosylated alpha-1-anti-trypsin, and fucosylated kininogen from 113 patients with cirrhosis and 164 serum samples from patients with cirrhosis plus HCC. We utilized two different methods, namely, stepwise penalized logistic regression (stepPLR) and model-based classification and regression trees (mob), along with the inclusion of clinical and demographic factors such as age and gender, to determine if these improved algorithms could be used to increase the detection of cancer. RESULTS AND DISCUSSION: The performance of multiple biomarkers was found to be better than that of individual biomarkers. Using several statistical methods, we were able to detect HCC in the background of cirrhosis with an area under the receiver operating characteristic curve of at least 0.95. stepPLR and mob demonstrated better predictive performance relative to logistic regression (LR), penalized LR and classification and regression trees (CART) used in our prior study based on three-fold cross-validation and leave one out cross-validation. In addition, mob provided unparalleled intuitive interpretation of results and potential cut-points for biomarker levels. The inclusion of age and gender improved the overall performance of both methods among all models considered, while the stratified male-only subset provided the best overall performance among all methods and models considered. CONCLUSIONS: In addition to multiple biomarkers, the incorporation of age and gender into statistical models significantly improved their predictive performance in the detection of HCC. BioMed Central 2013-11-11 /pmc/articles/PMC3980825/ /pubmed/24564861 http://dx.doi.org/10.1186/1755-8794-6-S3-S9 Text en Copyright © 2013 Wang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wang, Mengjun Mehta, Anand Block, Timothy M Marrero, Jorge Di Bisceglie, Adrian M Devarajan, Karthik A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables |
title | A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables |
title_full | A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables |
title_fullStr | A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables |
title_full_unstemmed | A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables |
title_short | A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables |
title_sort | comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980825/ https://www.ncbi.nlm.nih.gov/pubmed/24564861 http://dx.doi.org/10.1186/1755-8794-6-S3-S9 |
work_keys_str_mv | AT wangmengjun acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT mehtaanand acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT blocktimothym acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT marrerojorge acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT dibisceglieadrianm acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT devarajankarthik acomparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT wangmengjun comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT mehtaanand comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT blocktimothym comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT marrerojorge comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT dibisceglieadrianm comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables AT devarajankarthik comparisonofstatisticalmethodsforthedetectionofhepatocellularcarcinomabasedonserumbiomarkersandclinicalvariables |